DiaSys enters Chinese market via Vastec Medical deal:
This article was originally published in Clinica
Executive Summary
DiaSys has signed a three-year exclusive agreement with Vastec Medical, a Hong Kong and China-based medical products distribution company. Under the terms of the agreement, Vastec will distribute and service DiaSys' urine sediment workstations throughout China and Hong Kong. The deal, which initially provides for a minimum order of 36 workstations, also gives Vastec first refusal to distribute future DiaSys products in China and Hong Kong. Vastec's managing director K S Ho says laboratory operating costs are making urine sediment analysis a difficult test to justify in China and Hong Kong. DiaSys' R/S series workstations provide standardisation and automation at affordable prices, Mr Ho adds.